Posterior Reversible Encephalopathy Syndrome and Pregnancy: Case Report
DOI:
https://doi.org/10.24265/horizmed.2015.v15n3.13Keywords:
Encephalopathy, Pregnancy, Preeclampsia, HellpAbstract
Posterior Reversible Encephalopathy Syndrome (PRES) is a clinical and radiological condition given by neurologic signs along with characteristic imaging findings. During pregnancy, its presentation is associated to Eclampsia. We present the case of an 18-year-old patient who develops treatment refractory eclampsia and HELLP syndrome during immediate puerperium, thus leading to the diagnosis of PRES and referral to intensive care. Imaging assessment confirmed diagnosis, with successful results. PRES consists of a heterogeneous group of pathologic processes, triggered by multiple etiologies, in our case secondary to hypertensive encephalopathy caused by Preeclampsia-Eclampsia Syndrome. Association of PRES, Preeclampsia-Eclampsia Syndromeand HELLP such as the case of our patient, is extremely rare with limited amount of case reports.
Downloads
References
1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C,Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Feb 22; 334(8):494-500.
American College of Obstetricians and Gynecologist. Diagnosis and Management of Preeclampsia and Eclampsia. Centers for Disease Control and Prevention Washington DC: 2002, ACOG Practice Bulletin Nº 33.
Cunningham FG, Gant NF, LevenoKJ, editors. Hypertensive disorders of pregnancy. In: Williams Obstetrics. New York: McGraw Hill; 2001. p. 567–618.
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013:a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9947):980-1004.
Huarte Ciganda M, Modroño A, Larrañaga C. [Management ofhypertension in pregnancy]. An Sist Sanit Navar. 2009; 32 Suppl 1:91-103.
Waldron RL 2nd, Abbott DC, Vellody D. Computed tomography in preeclampsia-eclampsia syndrome. AJNR Am J Neuroradiol. 1985 May-Jun; 6(3):442-3.
Pereira PR, Pinho J, Rodrigues M, Rocha J, Sousa F, Amorim J, Ribeiro M, Rocha J, Ferreira C. Clinical, imagiological and etiological spectrum ofposterior reversible encephalopathy syndrome. Arq Neuropsiquiatr. 2015 Jan;73(1):36-40.
Marano E, Scuteri N, Vacca G, Orefice G. HELLP síndrome with reversible posterior leukoencephalopathy. Neurol Sci. 2003 Jun; 24(2):82-4.
Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001 Jan; 77(903):24-8.
Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR. Occipital lobeseizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia. 1998 Mar; 39(3):295-9.
Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinicalfeatures. AJNR Am JNeuroradiol. 2008 Jun; 29(6):1036-42.
Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol. 2001 Jun-Jul; 22(6):1068-70.
Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol.2005 Feb; 105(2):402-10.
Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol (1985).2011 Feb; 110(2):329-39. doi: 10.1152/japplphysiol.01159.2010. Epub2010 Nov 11.
American College of Obstetricians and Gynecologists; Task Forceon Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol.2013 Nov; 122(5):1122-31.
Magee LA, Pels A, Helewa M, Rey E, von DadelszenP; Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014 May; 36(5):416-41.
Roberts JM, Villar J, Arulkumaran S. Preventing and treating eclamptic seizures. BMJ. 2002 Sep 21; 325(7365):609-10.
Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995 Jul 27; 333(4):201-5.
Dietl J. The pathogenesis of pre-eclampsia: new aspects. J Perinat Med.2000;28 (6):464-71
Belfort MA, Anthony J, Saade GR, Allen JC Jr; Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003 Jan 23; 348(4):304-11.
Alexander JM, McIntire DD, Leveno KJ, Cunningham FG. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol. 2006 Oct;108(4):826-32.
Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol. 2004 Jun; 190(6):1520-6.
Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol. 1984 Apr 1; 148(7):951-63.
Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A,Ebrashy A, Bujold E. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther.2012; 31(3):141-6.
Grill S, Rusterholz C, Zanetti-Dällenbach R, TercanliS, Holzgreve W, Hahn S, andLapaire O. Potential markers of preeclampsia review. Reprod Biol Endocrinol. 2009 Jul 14; 7:70.
Polsani S, Phipps E, Jim B. Emerging new biomarkers of preeclampsia. Adv Chronic Kidney Dis. 2013 May; 20(3):271-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
